A detailed history of Two Sigma Investments, LP transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 27,800 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,800
Previous 490,516 94.33%
Holding current value
$0
Previous $421,000 89.55%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.17 - $1.92 $541,377 - $888,414
-462,716 Reduced 94.33%
27,800 $44,000
Q4 2023

Feb 14, 2024

BUY
$0.6 - $1.31 $50,212 - $109,631
83,688 Added 20.57%
490,516 $421,000
Q3 2023

Nov 14, 2023

BUY
$1.05 - $3.37 $73,913 - $237,227
70,394 Added 20.92%
406,828 $435,000
Q2 2023

Aug 14, 2023

SELL
$2.44 - $4.53 $13,634 - $25,313
-5,588 Reduced 1.63%
336,434 $871,000
Q1 2023

May 15, 2023

BUY
$3.72 - $5.4 $233,735 - $339,292
62,832 Added 22.51%
342,022 $1.4 Million
Q4 2022

Feb 14, 2023

BUY
$3.41 - $12.93 $65,642 - $248,902
19,250 Added 7.41%
279,190 $1.4 Million
Q3 2022

Nov 14, 2022

BUY
$12.59 - $17.67 $1.15 Million - $1.61 Million
91,020 Added 53.88%
259,940 $3.4 Million
Q2 2022

Aug 15, 2022

BUY
$10.58 - $17.5 $229,818 - $380,135
21,722 Added 14.76%
168,920 $2.17 Million
Q1 2022

May 16, 2022

SELL
$13.81 - $18.6 $1.24 Million - $1.66 Million
-89,461 Reduced 37.8%
147,198 $2.25 Million
Q4 2021

Feb 14, 2022

BUY
$17.26 - $22.02 $489,131 - $624,024
28,339 Added 13.6%
236,659 $4.19 Million
Q3 2021

Nov 15, 2021

BUY
$20.15 - $26.19 $3.92 Million - $5.09 Million
194,420 Added 1398.71%
208,320 $4.38 Million
Q2 2021

Aug 16, 2021

SELL
$15.06 - $30.03 $816,959 - $1.63 Million
-54,247 Reduced 79.6%
13,900 $274,000
Q1 2021

May 17, 2021

BUY
$24.99 - $31.93 $1.7 Million - $2.18 Million
68,147 New
68,147 $1.98 Million
Q4 2020

Feb 16, 2021

SELL
$16.21 - $31.44 $803,075 - $1.56 Million
-49,542 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$15.59 - $19.97 $11,333 - $14,518
727 Added 1.49%
49,542 $788,000
Q2 2020

Aug 14, 2020

BUY
$11.97 - $23.47 $584,315 - $1.15 Million
48,815 New
48,815 $964,000

Others Institutions Holding NGM

About NGM BIOPHARMACEUTICALS INC


  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.